Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Regulatory T cells (Tregs) are critical mediators of immune homeostasis. The co-stimulatory molecule CD27 is a marker of highly suppressive Tregs, although the role of the CD27-CD70 receptor-ligand interaction in Tregs is not clear. Here we show that after prolonged in vitro stimulation, a significant proportion of human Tregs gain stable CD70 expression while losing CD27. The expression of CD70 in expanded Tregs is associated with a profound loss of regulatory function and an unusual ability to provide CD70-directed co-stimulation to TCR-activated conventional T cells. Genetic deletion of CD70 or its blockade prevents Tregs from delivering this co-stimulatory signal, thus maintaining their regulatory activity. High resolution targeted single-cell RNA sequencing of human peripheral blood confirms the presence of CD27-CD70+ Treg cells. These findings have important implications for Treg-based clinical studies where cells are expanded over extended periods in order to achieve sufficient treatment doses.

Original publication

DOI

10.1038/s42003-020-1097-8

Type

Journal article

Journal

Commun Biol

Publication Date

14/07/2020

Volume

3

Keywords

Animals, CD27 Ligand, CRISPR-Associated Protein 9, CRISPR-Cas Systems, Female, Flow Cytometry, Forkhead Transcription Factors, Gene Editing, Gene Knockout Techniques, Humans, Mice, Inbred BALB C, Sequence Analysis, RNA, T-Lymphocytes, Regulatory, Transcriptome, Tumor Necrosis Factor Receptor Superfamily, Member 7